Document is current

Any future updates will be listed below

A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design

Crossref DOI link: https://doi.org/10.1186/1471-2369-15-153

Published Online: 2014-09-19

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark